Rosen, leading investor counsel, encourages regeneron pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – regn

New york, jan. 16, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of regeneron pharmaceuticals, inc. (nasdaq: regn) between november 2, 2023 and october 30, 2024, both dates inclusive (the “class period”). a class action lawsuit has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than march 10, 2025.
REGN Ratings Summary
REGN Quant Ranking